In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 4th, 2008 | 17 | Yes |
Popular Name: Ticlopidine hydrochloride Ticlopidine hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 53885-35-1 , 55142-85-3 , 62019-75-4 , [53885-35-1]
5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine
5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride
5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine
53885-35-1; D01028; Ticlid (TN); Ticlopidine hydrochloride (JP16/USAN)
53885-35-1; Prestwick_502; Ticlopidine hydrochloride
55142-85-3; C07140; Ticlopidine
55142-85-3; D08594; Ticlopidin-Puren (TN); Ticlopidine (INN)
CPD000048468; SAM001246558; Ticlopidine Hydrochloride
INN); Ticlopidine Hydrochloride (FDA
Thieno(3,2-c)pyridine, 4,5,6,7-tetrahydro-5-((2-chlorophenyl)methyl)-
Thieno(3,2-c)pyridine, 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydro-
Thieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-
Ticlid; Ticlodone; Ticlopid; Tiklyd
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.64 | 7.82 | -4.17 | 0 | 1 | 0 | 3 | 263.793 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 2.19e-02 g/l | DrugBank-approved |
Purity | BP/EP/JP/CP | APIChem |
Patent Database Links | EP0829482; EP1553091; EP1785144; EP1810693; US2007196504 | ChEBI |
Patent Database Links | EP1555032; EP1679067; EP1719526; EP1741713; EP1757250; EP1839648; EP1894567; EP1939188; EP1977766; EP1992346; US2004106626; US2004106833; US2004254182; US2005038030; US2005085497; US2005119312; US2005124661; US2005124664; US2005137216; US2005143384; US200 | ChEBI |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP02355t; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
Target | P2 Receptor | Selleck Chemicals |
Therapy | PAF inhibitor | SMDC Pharmakon |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP02355t; SALT: 1 hydrogen chloride | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CP2B6-3-E | Cytochrome P450 2B6 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 800 | 0.50 | ADME/T ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CP2B6_HUMAN | P20813 | Cytochrome P450 2B6, Human | 200 | 0.55 | ADME/T ≤ 10μM |
Description | Species |
---|---|
CYP2E1 reactions | |
Fatty acids | |
Xenobiotics |